Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SWB:GU5
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SWB:GU5
|
CN |
|
Great Portland Estates PLC
F:G9KB
|
UK |
|
N
|
Nektar Therapeutics
F:ITH
|
US |
|
EC World Real Estate Investment Trust
OTC:ECWDF
|
SG |
|
N
|
Nichicon Corp
F:NH4
|
JP |
|
KMD Brands Ltd
ASX:KMD
|
NZ |
|
C
|
Citizen Watch Co Ltd
OTC:CHCLY
|
JP |
|
B
|
Baylin Technologies Inc
F:5BT
|
CA |
|
B
|
BLIS Technologies Ltd
XBER:BXD
|
NZ |
|
T
|
THG PLC
OTC:THGHY
|
UK |
|
Ultra Electronics Holdings PLC
LSE:ULE
|
UK |
|
Supply@Me Capital PLC
LSE:SYME
|
UK |
|
A
|
Argosy Property Ltd
OTC:IGPYF
|
NZ |
|
F
|
Freshii Inc
F:3FI
|
CA |
|
Delcath Systems Inc
F:DV3R
|
US |
|
Yamaha Corp
OTC:YAMCF
|
JP |
|
N
|
Nexen Corp
KRX:005725
|
KR |
|
Furukawa Co Ltd
F:FUR
|
JP |
Wall St Price Targets
GU5 Price Targets Summary
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
According to Wall Street analysts, the average 1-year price target for GU5 is 1.86 EUR with a low forecast of 1.15 EUR and a high forecast of 2.63 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GU5's stock price target?
Price Target
1.86
EUR
According to Wall Street analysts, the average 1-year price target for GU5 is 1.86 EUR with a low forecast of 1.15 EUR and a high forecast of 2.63 EUR.
What is the Revenue forecast for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 3 years is 5%.
What is the Gross Profit forecast for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 2 years is 5%.
What is the Operating Income forecast for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 3 years is 10%.
What is the Pre-Tax Income forecast for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is 7%.
What is the Net Income forecast for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 3 years is 7%.
